Phase 2 study of everolimus monotherapy in patients with nonfunctioning neuroendocrine tumors or pheochromocytomas/paragangliomas.

Phase 2 study of everolimus monotherapy in patients with nonfunctioning neuroendocrine tumors or pheochromocytomas/paragangliomas.

Item
http://www.wikidata.org/entity/Q33401986
Sunitinib for refractory malignant pheochromocytoma: two case reports.Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatmentA multicenter phase II study of everolimus in patients with progressive unresectable adenoid cystic carcinoma.Oncogenic features of the bone morphogenic protein 7 (BMP7) in pheochromocytoma.Efficacy and Safety of Everolimus in Extrapancreatic Neuroendocrine Tumor: A Comprehensive Review of Literature.Current and future treatments for malignant pheochromocytoma and sympathetic paraganglioma.Evidence for rapamycin toxicity in pancreatic β-cells and a review of the underlying molecular mechanisms.Diagnosis and management of pheochromocytoma: a practical guide to clinicians.Paraganglioma and phaeochromocytoma: from genetics to personalized medicine.Hyperglycemia Associated With Targeted Oncologic Treatment: Mechanisms and Management.Efficacy and safety of everolimus and sunitinib in patients with gastroenteropancreatic neuroendocrine tumor.Treatment-related fatigue with everolimus and temsirolimus in patients with cancer-a meta-analysis of clinical trials.Clinical outcomes of everolimus in patients with advanced, nonfunctioning pancreatic neuroendocrine tumors: a multicenter study in Korea.
P2860

Phase 2 study of everolimus monotherapy in patients with nonfunctioning neuroendocrine tumors or pheochromocytomas/paragangliomas.

Item
http://www.wikidata.org/entity/Q33401986
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Phase 2 study of everolimus mo ...... ochromocytomas/paragangliomas.
@ast
Phase 2 study of everolimus mo ...... ochromocytomas/paragangliomas.
@en
type
label
Phase 2 study of everolimus mo ...... ochromocytomas/paragangliomas.
@ast
Phase 2 study of everolimus mo ...... ochromocytomas/paragangliomas.
@en
prefLabel
Phase 2 study of everolimus mo ...... ochromocytomas/paragangliomas.
@ast
Phase 2 study of everolimus mo ...... ochromocytomas/paragangliomas.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Phase 2 study of everolimus mo ...... ochromocytomas/paragangliomas.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921